Preview Mode Links will not work in preview mode

Dec 20, 2021

Featuring an interview with Dr Arvind Dasari, including the following topics:

  • Advances in the genetic profiling of and targeted therapies for colorectal cancer
  • Management of metastatic disease
  • Overview of available salvage therapies: Regorafenib and TAS-102
  • Considerations for resistance to EGFR-targeted therapies

CME information and select publications